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Abstract: BACKGROUND: p-Phenylenediamine (PPD) is a strong contact allergen used in hair dye
known to cause allergic contact dermatitis (ACD). Both private and occupational exposure to PPD is
frequent, but the effect of PPD exposure in non-allergic occupational exposed individuals is unknown. OB-
JECTIVE: To investigate effects of PPD exposure on the skin of occupationally exposed individuals with
and without clinical symptoms. METHODS: Skin biopsies were collected from 4 mild and 5 severe PPD
ACD patients and 7 hairdressers without contact dermatitis on day 4 after patch testing with 1% PPD
in vaseline. RNA-sequencing and transcriptomics analyses were performed and confirmed by qRT-PCR.
Protein expression was analyzed in skin from 4 hairdressers and 1 ACD patient with immunofluorescence
staining. Reconstructed human epidermis was used to test the effects of PPD in vitro. RESULTS: RNA-
sequencing demonstrated down-regulation of tight junction (TJ) and stratum corneum (SC) proteins in
skin of severe ACD patients after PPD exposure. Claudin-1 (CLDN1), claudin-8 (CLDN8), claudin-11
(CLDN11), CLMP, occludin, MAGI1, and MAGI2 expression were downregulated in severe ACD pa-
tients. CLDN1 and CLMP expression were downregulated in non-responding hairdressers and mild ACD
patients. Filaggrin-1(FLG1), filaggrin-2 (FLG2) and loricrin expression were downregulated in ACD in-
dividuals. Confocal microscopy images showed down regulation of claudin-1 and filaggrin 1 and 2. In
contrast, 3D skin cultures showed up-regulation of filaggrin-1 in response to PPD but down-regulation
of filaggrin-2. CONCLUSION: PPD-exposed skin is associated with extensive transcriptomic changes
including down-regulation of TJ and SC proteins even in the absence of clinical symptoms.
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Background: p-Phenylenediamine (PPD) is a strong contact allergen used in hair dye  30 
known to cause allergic contact dermatitis (ACD). Both private and occupational exposure to 31 
PPD is frequent, but the effect of PPD exposure in non-allergic occupational exposed 32 
individuals is unknown. 33 
Objective: To investigate effects of PPD exposure on the skin of occupationally exposed 34 
individuals with and  without clinical symptoms. 35 
Methods: Skin biopsies were collected from 4 mild and 5 severe PPD ACD patients and 7 36 
hairdressers without contact dermatitis on day 4 after patch testing with 1% PPD in vaseline. 37 
RNA-sequencing and transcriptomics analyses were performed and confirmed by qRT-PCR. 38 
Protein expression was analyzed in skin from 4 hairdressers and 1 ACD patient with 39 
immunofluorescence staining. Reconstructed human epidermis was used to test the effects of 40 
PPD in vitro. 41 
Results: RNA-sequencing demonstrated down-regulation of tight junction (TJ) and 42 
stratum corneum (SC) proteins in skin of severe ACD patients after PPD exposure. Claudin-1 43 
(CLDN1), claudin-8 (CLDN8), claudin-11 (CLDN11), CLMP, occludin, MAGI1, and 44 
MAGI2 expression were downregulated in severe ACD patients. CLDN1 and CLMP 45 
expression were downregulated in non-responding hairdressers and mild ACD patients. 46 
Filaggrin-1(FLG1), filaggrin-2 (FLG2) and loricrin expression were downregulated in ACD 47 
individuals. Confocal microscopy images showed down regulation of claudin-1 and filaggrin 48 
1 and 2. In contrast, 3D skin cultures showed up-regulation of filaggrin-1 in response to PPD 49 
but down-regulation of filaggrin-2. 50 
Conclusion: PPD-exposed skin is associated with extensive transcriptomic changes 51 





Clinical implications 54 
Better understanding mechanisms of skin barrier damage caused by strong contact 55 
allergens can improve treatment and assist in prevention of occupational ACD. 56 
Capsule summary: 57 
Mechanisms of skin barrier defects in para-phenylenediamine allergic contact 58 
dermatitis patients and healthy hairdressers after exposure demonstrate significant 59 
downregulation of tight junction and stratum corneum proteins. 60 
Abbreviations 61 
ACD: Allergic contact dermatitis 62 
AD: Atopic dermatitis  63 
PPD: p-Phenylenediamine 64 
CLDN: Claudin 65 
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IVL: Involucrin 69 
LOR: Loricrin 70 
MAGI1: Membrane-Associated Guanylate Kinase Inverted 1 71 
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ROS: Reactive oxygen species 74 
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TJ: Tight junction 76 
VAS: Vaseline 77 
Keywords 78 
Allergic contact dermatitis, p-Phenylenediamine, hair dye contact hypersensitivity, tight 79 





Allergic contact dermatitis (ACD), also referred to as contact hypersensitivity reaction, is 82 
mediated by T-cells and the lesion typically appears 2-7 days after exposure to the contact 83 
allergen (1). The presentation and severity of the clinical reactions depends on the exposure 84 
site and type of contact allergen, and the diagnosis of contact dermatitis is given after a 85 
positive patch test to a clinically relevant contact allergen (2). ACD reactions to p-86 
phenylenediamine (PPD) typically result in eczema and typical symptoms include itchiness, 87 
redness and swelling, which can be severe with vesicles at the site of contact allergen 88 
exposure. Severe reactions to hair dye can cause swelling of the face and obstruction of the 89 
airways, which can even result in hospitalization. Other clinical manifestations include severe 90 
scalp eczema and complete or partial hair-loss. Additional stimulus, such as cold and dry 91 
weather, abrasive activity in damp conditions, and exposure to chemical or mechanical stress 92 
may contribute to the severity of lesions. Together with irritant contact dermatitis, ACD is 93 
one of the most abundant occupational diseases in Europe, resulting in a considerable 94 
socioeconomic burden due to cost of treatment and loss of productivity (3).  95 
Occupations particularly at risk of developing ACD include hairdressers, who have regular 96 
contact with irritants and contact allergens. The hair dye component PPD used in dark 97 
permanent hair dyes is a well-known, strong allergen leading to ACD after as little as two 98 
exposures (1, 4). Over the past 15 years, the hair dye industry has been attempting to 99 
chemically modify or find alternatives to PPD to improve the safety of cosmetic products, 100 
thus synthesizing an array of new ingredients with various degree of success (5). Both 101 
hairdressers and consumers still experience a high level of exposure though only 0.8% of the 102 
general population in Europe is sensitized to PPD (6). Hair dye is the main source of PPD-103 
exposure, but this contact sensitizing chemical is also an ingredient for temporary black 104 




Making individualized hair-dye mixtures or combining different products at home may also 106 
increase the exposure to PPD also for personal use (9). Several studies have demonstrated 107 
how using gloves when handling the dye mixtures and improving working habits can 108 
decrease the hairdresser's exposure to PPD (10, 11). However, some exposure is unavoidable 109 
regardless of the health and safety training received by the hairdresser. Contact with PPD 110 
might occur when cutting newly dyed hair or by contamination in the workplace (12). Thus, 111 
it is important to gain a better understanding of the effects of PPD exposure on the human 112 
body, especially on the skin barrier.  113 
PPD has been shown to sensitize most exposed individuals after only two exposures (13), 114 
which would make most hairdressers sensitized to PPD, but this is not the case. Previous 115 
results by Uter et al., showed that 20% of the patch tested hairdressers had ACD to PPD 116 
based on data collected from the Information Network of Departments of Dermatology 117 
(2007-2012) on 824 female hairdressers (14). Occupationally exposed individuals might 118 
therefore have other mechanisms to protect against PPD exposure induced sensitization and 119 
tissue damage. PPD is a highly reactive small aromatic compound, and ACD to PPD is 120 
thought to be initiated when PPD or its immediate oxidative products, react with proteins in 121 
the skin (1). Among the suggested mechanisms, is the oxidation of the amino acid cysteine in 122 
human serum albumin which can then function as an immunogenic epitope (15). In contrast, 123 
acetylation of PPD by N-acetyltransferase from keratinocytes deactivates its sensitizing 124 
potential (16).  125 
The skin barrier is the first layer of defense against potential pathogens, pollutants and 126 
contact allergens. In addition to the physical barrier provided by keratinocytes, the skin 127 
barrier contains elements of innate immunity such as anti-microbial peptides, pattern 128 
recognition receptor systems, lipids, ions designed to prevent colonization by pathogens, and 129 




formation of tight junctions (TJ). TJs seal the epidermal layer at the stratum granulosum 131 
against the outer environment. It is now known that disruption of epithelial barrier by 132 
dysregulated TJs and stratum corneum (SC) proteins is one of the underlying causes of 133 
contact allergic skin diseases (17) 134 
 TJ family proteins claudin-1 (CLDN-1), CLDN-8 and CLDN-23 are expressed at low 135 
levels in the lesional skin of atopic dermatitis (AD) patients. (18, 19) and polymorphisms in 136 
the claudin-1 gene is associated with increased sensitization to contact allergens (20). 137 
Filaggrin-1 (FLG) and filaggrin-2 (FLG-2) are expressed at lower levels in lesional skin of 138 
AD patients (21). FLG mutations in humans lead to a susceptibility to hand eczema, 139 
childhood-onset AD and sensitization to contact allergens where the amount of filaggrin in 140 
epidermis is correlated with disease severity and quality of life (22-24). A dysfunctional skin 141 
barrier is therefore not only involved in the development but also in the severity of skin 142 
diseases.  143 
The full extent of changes in the epidermal barrier in ACD to PPD are currently unknown. 144 
In the present study, we report RNA-sequencing on skin biopsies from PPD ACD patients 145 
and clinically non-responding hairdressers. We demonstrate changes in the level of 146 
expression in SC barrier proteins and TJs in PPD-exposed skin, with a multi-level damage to 147 
the skin barrier being observed not only in skin of ACD patients but also show the same 148 




Materials and methods 150 
Study population 151 
The study included two groups: a PPD ACD patient group (N=10) recruited from the 152 
Department of Dermatology and Allergy at Gentofte Hospital, Copenhagen (Denmark) and a 153 
group of PPD-exposed hairdressers without ACD referred to as non-responders (N=11). The 154 
allergic group was diagnosed with ACD to PPD within the past 5 years. Non-responders were 155 
hairdressers with 5 or more years in the field and with no history of ACD, recruited from 156 
hairdresser salons and through the hairdresser unions platforms. The participants were adults 157 
between 18 and 60 years, further characteristics are listed in table 1. Patients with other 158 
inflammatory skin diseases or receiving immunosuppressive medication were excluded. All 159 
participants gave informed written consent and the study was conducted in accordance with 160 
the Helsinki declaration and approved by local ethics committee HGH-2015-032 (I-Suite nr: 161 
03984).  162 
 163 
Patch test 164 
A total of 10 ACD patients and 11 hairdressers without and ACD were patch tested with 165 
20 mg of 1% PPD in vaseline (VAS) and a vehicle VAS control applied in 8 mm Finn 166 
chambers on the buttocks, affixed with Scanpore tape with an occlusion time of 48 h. The 167 
patch test was scored on days 2 and 4 according to the European Society of Contact 168 
Dermatitis (ESCD) criteria (IR, doubtful, 1+, 2+ or 3+) (2). Punch biopsies (4 mm) were 169 
taken on day 4 from both the PPD and vehicle test-site.  170 
RNA sequencing 171 
Nine biopsies from PPD ACD patients and 7 biopsies from PPD non-responders was used 172 
for RNA sequencing. The biopsies were placed in RNAlater and frozen in liquid nitrogen 173 
before storage at -80 °C. Total RNA was prepared from skin biopsies using the RNeasy 174 




RNA was determined with Qubit® 1.0 fluorometer (Life Technologies, California, USA) and 176 
Bioanalyzer 2100 (Agilent, Waldbronn, Germany) and samples with RNA integrity number 177 
>5.0 were chosen for sequencing. Library preparation for RNA-seq was performed using the 178 
TruSeq Stranded mRNA Sample Prep Kit (Illumina, Inc., California, USA).  179 
Total RNA samples (400 ng) were ribosome depleted and then reverse-transcribed into 180 
double-stranded cDNA with actinomycin added during first-strand synthesis. The cDNA 181 
samples were fragmented, end-repaired and polyadenylated before ligation to the TruSeq 182 
adapters. The adapters contain the index for multiplexing. Fragments containing TruSeq 183 
adapters on both ends were selectively enriched with PCR. The quality and quantity of the 184 
enriched libraries were validated using Qubit® 1.0 Fluorometer and the Bioanalyzer 2100 185 
(Agilent, Waldbronn, Germany). The product is a smear with an average fragment size of 186 
approximately 360 bp. The libraries were normalized to 10 nM in Tris-Cl 10 mM, pH 8.5 187 
with 0.1% Tween 20. The TruSeq SR Cluster Kit v4-cBot-HS or TruSeq PE Cluster Kit v4-188 
cBot-HS (Illumina, Inc., California, USA) was used for cluster generation using 8 pM of 189 
pooled normalized libraries on the cBOT. Sequencing was performed on the Illumina HiSeq 190 
2500 paired-end at 2x126 bp or single-end 126 bp using the TruSeq SBS Kit v4-HS 191 
(Illumina, Inc., California, USA). 192 
Quality control on the raw sequence data was performed with FastQC (v.0.10.0, Babraham 193 
Institute, Cambridge, UK) and mapped to the Homo sapiens genome (GRCh38 build) using 194 
RSEM (v1.2.12) (25) implementation of Bowtie software (v 1.0.0) (26) alignment program 195 
with the Ensembl annotation (v 75). Gene and isoform level abundances were quantified as 196 
RPKM values. Clustering analyses were performed using the “ward.D2” clustering algorithm 197 
implemented in the “hclust” function of R statistics package. Heatmap plots were performed 198 




Differential expression analysis between two groups was performed using edgeR 200 
Bioconductor package (27). Genes present in less than 75% of samples in both conditions 201 
were excluded. Q-values were calculated using the Benjamini-Hochberg method and genes 202 
with a q-value <0.015 and an absolute value of log2 (fold change)>1 were kept for further 203 
analysis. Gene ontology (GO) term enrichment analysis was performed using GOseq 204 
Bioconductor package (28) using the Wallenius approximation. Pathway analysis was done 205 
using the Enricher platform with the Panther database (29, 30). Significant pathways were 206 
defined as pathways with an adjusted P-value below 0.01. 207 
Confocal microscopy 208 
Biopsies were collected on day 4 from 4 non-responder hairdressers and 1 PPD ACD 209 
patient. Upon collection, the biopsies were embedded in TissueTek, frozen in liquid nitrogen 210 
and stored at -80 °C. The biopsies were cut in 7 µm slices, fixed with 4% PFA on glass slides 211 
and stained with primary antibodies against claudin-1 (Abcam FLG01), CLMP (Abcam 212 
ab171552), filaggrin-1(Abcam ab3137), filaggrin-2 (Abcam ab122011), secondary 213 
fluorochrome labeled antibodies, goat anti-rabbit AF546 (Invitrogen A-11010), goat anti-214 
rabbit AF488 (Invitrogen A-11034), and goat anti-mouse AF546 (Invitrogen A-11030). 215 
Apoptosis stainings were performed using Click-iT TUNEL Alexa Flour 674 Imaging Assay 216 
(Bioscience). 217 
3D Skin cultures 218 
Reconstructed human epidermis grown for 13 days (Episkin, France) were cultured 219 
overnight in an air-liquid interface prior to use. Cultures were stimulated with 0.5% PPD in 220 
PBS, 0.5% H2O2 in PBS or PBS alone. Skin cultures were collected at 8 h and 24 h and 221 





Significantly differentially expressed genes were defined as genes with a false discovery 224 
rate (FDR) below 0.015. Gene expression between paired samples, PPD-exposed and VAS 225 
exposed skin from the same individual were analyzed using the Wilcoxon signed-ranked test 226 
and comparison between groups was done using the Mann-Whitney test. Venn diagrams of 227 
significantly regulated genes between comparison groups were visualized with the online 228 
application “genevenn.sourceforge.net” 229 
 230 
Results  231 
Altered gene expression profiles linked to severity of lesional skin  232 
All patch tests from non-responder hairdressers and the histology of tissue sections 233 
showed no remarkable changes, whereas ACD patients showed reactions ranging from mild 234 
swelling and redness to severe blister formation (3+ patch test reaction) followed by necrosis 235 
(Figure 1A). RNA sequencing, subsequent principal component analysis (PCA) and 236 
hierarchical clustering of skin biopsies collected from patch tested individuals showed a 237 
unique gene expression profile in PPD-exposed skin in PPD ACD patients with skin lesions 238 
with higher degree of severity (graded +2 and +3) (Figure 1B). Gene expression profile of 239 
mild ACD individuals (graded +1 or doubtful) clustered more close to vaseline exposed skin 240 
from non-responders and PPD ACD patients, as well as PPD-exposed skin from non-241 
responder individuals. The RNA expression in vaseline controls from ACD individuals and 242 
non-responder hairdressers did not differ from each other, only one gene out of 21175 243 
sequences showed significant differential expression. Overall, hierarchical clustering of skin 244 
biopsies according to the top 2000 genes showed that the transcriptomic signature of PPD-245 
exposed skin depends on the severity of the clinical manifestation. Severe ACD reactions 246 
clustered together, whereas samples from mild ACD reactions and non-responder PPD-247 




thickening of the skin and inflammatory papules were visible in the skin of severe and mild 249 
ACD reactions on day 2, increasing in severity on day 4. Skin characteristics and phenotype 250 
did not change with VAS stimulation and in non-responders at day 2 or day 4 (Fig 1D) 251 
 252 
Gene expression patterns differ between ACD and non-responder groups 253 
Next, we investigated the enriched pathways for the differentially expressed genes 254 
between severe and mild ACD reactions and non-responder skin biopsies. Differentially 255 
expressed genes from the three groups were depicted as upregulated (Figure 2A) and 256 
downregulated genes (Figure 2B) and compared between the three groups (upregulated 257 
Figure 2C, downregulated Figure 2D). 2636 upregulated genes were found to be unique for 258 
the severe ACD group, 53 for the mild ACD group and 22 for the non-responder group, 259 
further 376 genes were upregulated in all groups. The shared or unique genes in each group 260 
were analyzed for significant pathway associations (Figure 2A). Upregulated pathways in 261 
ACD individuals belonged to immune response pathways involved in T-cell recruitment and 262 
activation, inflammation, cytokine and chemokine signaling and Toll-like receptor signaling. 263 
In the severe ACD group, pathways involved in cell damage and death were also significantly 264 
upregulated. The non-responder group shared upregulation of T cells activation and 265 
inflammatory cytokine and chemokine signaling. Unique to non-responders was a pathway 266 
involved in serotonin degradation. Among the downregulated genes, there were 3382 unique 267 
genes in the severe ACD group, 69 genes in the mild ACD group and 17 genes in the non-268 
responders (Figure 2D). The most significantly downregulated gene pathways included cell 269 
adhesion, tissue regeneration and cell metabolism (Figure 2B). Association of downregulated 270 
genes with cellular adhesion and cellular junction pathways, as well as identification of 271 




investigate the state of skin barrier and cell adhesion components in PPD ACD skin (Figure 273 
3). 274 
 275 
Dysregulation of cell-cell junction genes takes place in both non-responders and 276 
individuals with ACD 277 
To analyze the expression of the TJ components in the skin, 47 genes with known 278 
association of function with the TJ gene family were curated from Gene Ontology (GO), 279 
Kyoto Encyclopedia of Genes and Genomes (KEGG) databases. Out of the 47 genes, 37 were 280 
expressed in the skin, taking a mean expression threshold value of >10 unique read counts. 281 
Analysis of the TJ gene expression in non-responders, mild ACD and severe ACD skin 282 
groups revealed that 15 out of 32 (47%) TJ genes were significantly downregulated in one or 283 
more groups (Figure 3A). All the 15 genes were significantly downregulated in severe ACD 284 
individuals, whereas CLDN1 and CXADR-like membrane protein (CLMP) were 285 
significantly downregulated in the mild ACD group. CLMP and CLDN1 down-regulation did 286 
not reach statistical significance in the PPD-exposed non-responder group but showed a 287 
similar pattern to the downregulation observed in PPD-exposed ACD individuals (Figure 288 
3B). Validation of RNA sequencing results with qPCR confirmed the findings for TJ genes 289 
CLDN1, CLDN8 and CLMP (Figure 3C). PPD exposure also affected the expression of gap-290 
junctions, desmosomes and keratins in all groups. The degree of dysregulation correlated 291 
with the severity of clinical symptoms and as such, most genes were deregulated in severe 292 
ACD reactions (Figure 3D).  293 
 294 
PPD causes dysregulation of filaggrin family proteins in ACD skin 295 
In line with downregulated pathways identified in our differential expression analysis of 296 




filaggrin family genes (FLG, FLG2, IVL, CRINN, LOR, RPTN, TCHH, TCHHL1, HRNR) 298 
and found 5 (56%) differentially expressed genes in one or more groups after PPD exposure 299 
(Figure 4A). Severe ACD reactions to PPD were associated with mRNA down-regulation of 300 
4 filaggrin family members; FLG1, FLG2, loricrin (LOR) and cornulin (CRNN) (Figure 4A). 301 
The analyses of expression levels showed a decrease in some individuals in the mild ACD 302 
and non-responder group, whereas the effect was more pronounced in the severe ACD group, 303 
which showed a stronger decrease (Figure 4B). In contrast, involucrin (IVL) was 304 
significantly upregulated in the patients with severe ACD reactions but remained constant in 305 
mild ACD and the non-responder groups. This pattern was also seen in correlation analyses 306 
between differentially expressed TJ and SC genes (Figure E1). Only involucrin expression 307 
negatively correlated with other barrier genes in the overall analysis (Figure E1A), all others 308 
showed either no correlation or a positive correlation. 309 
 310 
Both ACD patients and non-responder individuals showed decreased expression of 311 
barrier proteins by PPD 312 
Changes in barrier protein expression levels and their location in epidermis were 313 
visualized by confocal microscopy in skin biopsies from day 4 of patch test with PPD from 4 314 
non-responder hairdressers and 1 severe ACD patient (Figure 5).  TJ proteins, claudin 1 and 315 
CLMP were localized to the cell surface membrane forming a net-like pattern between the 316 
keratinocytes throughout epidermis in VAS controls of both the non-responder hairdressers 317 
and the severe ACD individual (Figure 5A). Claudin 1 protein expression decreased after 318 
PPD exposure in non-responder individuals but the net-like structure in the epidermis 319 
remained intact. PPD exposure had only limited visual effect on CLMP protein expression 320 




complete disruption of the epidermis in the severe ACD individual, causing the 322 
disappearance of the net-like structure of both claudin 1 and CLMP.  323 
Exposure to PPD decreased protein expression of FLG1 and FLG2 in both ACD and non-324 
responder individuals. Although an even distribution of both FLG1 and FLG2 proteins was 325 
observed in the outer layer of epidermis in the VAS controls of both non-responder 326 
hairdressers and severe ACD (Figure 5B). FLG2 was also expressed in basal membrane and 327 
this expression did not appear to be affected by PPD exposure in non-responder individuals 328 
(Figure 5B). 329 
 330 
PPD affected expression patterns of claudin-1 and CLMP and decreased the 331 
expression of filaggrin-2 in cultures of skin equivalents without inducing apoptosis 332 
 Since PPD is highly oxidative, we tested its direct toxicity on healthy skin cultures after 8 333 
and 24 hours of exposure. There was no indication of increased apoptosis after PPD 334 
exposure, though a general cell death in the basal membrane was observed after 24 h in all 335 
cultures. We next investigated the expression of barrier proteins and found slight decrease in 336 
CLND1 expression at the cell surface of keratinocytes with no signs of disorganization 8 h 337 
after PPD exposure. Hydrogen peroxide was applied to skin cultures as a positive control for 338 
oxidative stress, and it resulted in a significant decrease in CLDN1 expression. In healthy 339 
human skin, CLMP protein is mainly expressed at the cell membrane and, in lower levels, at 340 
the cytosol. After exposing skin to PPD for 8 h, we observed a decreased expression, but 341 
remained localized to cell surface. In contrast, hydrogen peroxide exposure resulted in 342 
dispersion of protein expression at the cell surface, but a more homogenous expression was 343 
observed in the cytosol. After PPD or hydrogen peroxide exposure, the FLG1 levels in skin 344 










The present study provides an in-depth analysis of the changes in the epithelial barrier 349 
components after exposure to PPD, a strong contact allergen often found in dark hair dyes. 350 
Hairdressers, who were repeatedly exposed to PPD due to their occupation, but never showed 351 
signs of contact dermatitis might tolerate this exposure and we therefore investigated their 352 
skin response to PPD exposure. The effect of PPD exposure was compared between 3 groups; 353 
non-responder hairdressers, mild and severe ACD individuals. The exact mechanism for 354 
sensitization to contact allergens is unknown; one theory is that the patients are sensitized due 355 
to inherent skin barrier defects leading to increased permeability of the skin. Most 356 
hairdressers do not develop ACD to PPD despite being exposed to the contact allergen for 357 
prolonged periods and multiple times. It can be suggested that non-responder individuals 358 
have a stable and strong epidermal barrier offering protection and tolerance towards this 359 
contact allergen. The analyses of vaseline exposed skins in both groups answered this 360 
question. Interestingly, our study did not indicate any differences in skin barrier protein 361 
expression in ACD patients and non-responder hairdressers upon vaseline exposure.  362 
Overall, TJ and SC proteins showed similar expression levels in both ACD patients and 363 
non-responders. In view of these results, we propose that the development of ACD lesions is 364 
not driven by inherent differences in skin barrier strength and stability between ACD patients 365 
and non-responders, but rather a result of immune response, tissue signaling, metabolism or 366 
inflammation caused by PPD exposure.  367 
Expression of TJ proteins CLDN1 and CLMP were downregulated in both mild and 368 
severe ACD, as well as in non-responders after PPD exposure, suggesting that PPD exposure 369 
disturbs the expression levels of these TJ proteins, even when there is no clinical symptoms. 370 
The rest of significantly differentially expressed TJ and SC barrier molecules were mainly 371 




mild ACD group, where inflammation was also present. Confocal microscopy imaging of 373 
claudin 1, filaggrin-1 and filaggrin 2 confirms the decrease of these barrier molecules in non-374 
responding individuals. Skin inflammation in AD, contact dermatitis and psoriasis have been 375 
reported to down-regulate fillagrin-1, filagrin-2 and claudin-1 (31, 32). Together this suggests 376 
that only CLDN1 and CLMP down-regulation is directly caused by PPD exposure and that 377 
the remaining dysregulation of TJ proteins is probably caused by the subsequent 378 
inflammation.  379 
PPD is a highly reactive chemical and has a half-life of a few hours on human skin (33). If 380 
left in contact with oxygen it polymerizes into its trimer Bandrowski's base, which also has 381 
an immune stimulating capacity (34). In healthy skin, PPD is N-acetylated to a safe 382 
metabolite in the uppermost layers of the skin (35). When PPD concentrations saturate the N-383 
acetyltransferases in the skin, the remaining PPD can oxidize and cleave a wide range of 384 
proteins on the cell surface, releasing non-self-cleaved peptides into the tissue environment. 385 
Reactive oxygen species (ROS) are formed during oxidation of PPD, and these activate 386 
innate immune response and recruitment of non-specific lymphocytes and direct them to the 387 
contact site (36). Specific epitopes and the type of signals that reach skin-resident antigen-388 
presenting cells are currently unknown. Skin lesions in PPD ACD individuals are persistent 389 
and lesions can reoccur in previously exposed sites indicating formation of allergen-specific 390 
memory cells in PPD ACD individuals. 391 
Early events in ACD resembles that of irritant contact dermatitis, which involves skin 392 
barrier damage or stress resulting in the activation of innate immune cells (37). Most contact 393 
allergens, including PPD are known to have irritant properties. In the present study, we 394 
attempted to limit the irritant response by using a standard concentration of PPD optimized 395 
for detecting ACD without causing clinically visible irritant reactions. The direct damage of 396 




increases the risk of both irritant contact dermatitis and ACD to other allergens. Damage to 398 
the epithelium was evident in the skin of non-responder hairdressers 4 days after PPD 399 
exposure, when the clinical manifestations were fully visible in ACD patients. However, a 400 
more extensive analysis at earlier time points is needed to conclude, if there is a difference in 401 
immediate response to PPD between non-responders and ACD patients. 402 
Non-responders do not display dysregulation of the epidermal barrier except for CLDN-1 403 
and CLMP on day 4 after PPD exposure. We propose that the higher stability of the 404 
epidermal barrier in non-responding individuals upon exposure to PPD is due to differences 405 
in immune response and possibly a more efficient conversion of PPD to its safe N-acetylated 406 
product. Differences in immune response may be due to a higher threshold for innate immune 407 
response activation, resistance to irritant exposure in non-responding individuals or the 408 
development of immune tolerance. More research is needed to answer these questions. The 409 
stimulation of healthy keratinocytes in skin cultures led to a higher expression and displayed 410 
a more coherent protein localization of major barrier proteins FLG1 and CLDN1. This 411 
observation might indicate that a healthy tissue response to PPD exposure upregulates its key 412 
proteins, strengthening the epidermal barrier. This response might be lost amid the 413 
inflammatory environment in individuals with ACD.  414 
In conclusion, we identified the state of skin barrier in terms of tight junction and stratum 415 
corneum proteins in individuals with ACD to PPD and in occupationally exposed non-416 
responders. We observed that the majority of TJ and SC proteins were significantly 417 
downregulated in the skin, which was significantly reduced in severe ACD patients and to a 418 
lesser extent in mild ACD patients. We identified two TJ proteins, CLDN1 and CLMP that 419 
are also downregulated in the skin of non-responder individuals upon PPD exposure. This 420 
direct barrier damage may be the outcome of the highly sensitizing nature of PPD and 421 
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Table 1. Patient characteristics 430 















Non-responders (7) F 32.1 0 0/7 0/7 0/7 7/7 
Mild ACD (4) F 36.3 ? / +1 3/4 4/4 2/4 2/4 
Severe ACD (5) F 45.6 +2/+3 5/5 3/5 3/5 0/5 
 431 
Characteristics of the individuals included for NGS analysis. Individuals from the non-432 
responder group did not have diagnosed allergies, atopic dermatitis or contact dermatitis. 433 
Occupational exposure was based on the participants work and own report of exposure. All PPD 434 
ACD individuals had a history of rash upon PPD exposure either from hair dyes, dark henna 435 
tattoos, photographic developer chemicals or other known sources of PPD exposure. Mild 436 
reactions were defined as doubtful reactions (?) and positive (+1) and severe reactions was 437 




Figure 1. Reactions to PPD patch test in non-responder and ACD individuals.  439 
Clinical reactions and corresponding hematoxylin and eosin (H&E) staining of tissues on day 440 
4 after patch testing with 1% PPD in VAS or control (VAS only) (A). 3D PCA plot of sample 441 
clustering in top 2000 differential expressed genes demonstrated a distinct clustering of 442 
severe lesions (B). Hierarchical clustering of samples in top 2000 differentially expressed 443 
genes; severe ACD reactions (red) n=5, mild ACD reactions (yellow) n=4, PPD-exposed skin 444 
from non-responder individuals (NR) (green) n=7 and VAS controls (purple) n= 16 (C). Skin 445 
lesions in response to PPD and VAS as control on days 2 and 4 after patch is applied (D).   446 
 447 
Figure 2. Pathway analysis of differentially expressed genes after PPD exposure. 448 
Comparison and pathway analysis of significantly upregulated (A) or downregulated (B) 449 
genes among severe ACD reactions (red) n=5, mild ACD reactions (yellow) n=4, PPD-450 
exposed skin from non-responder individuals (NR) (blue) n=7 compared to their vaseline 451 
controls (significance defined as a fdr > 0.015). Pathway analysis using the EnrichR/Panther 452 
databases of up- or downregulated genes in all groups and in genes overlapping between one 453 
or more groups. The number of involved genes in each pathway is indicated by N in the 454 
tables. Venn diagrams indicating the number of unique and shared genes significantly 455 
upregulated (C) or downregulated (D) between comparisons. 456 
 457 
Figure 3. Significantly regulated TJ proteins in PPD-exposed skin. Heatmap showing 458 
the log2 fold change of significantly differentially expressed TJ proteins in PPD exposed skin 459 
compared to vaseline controls in one or more groups; non-responder (NR), mild ACD 460 
reactions (mild) and severe ACD reactions (severe) (A). significance in the individual groups 461 
is indicated by * (fdr < 0.015). Scatter plots for the top 8 most significantly differentially 462 




were analyzed using paired or non-paired data (Wilcoxon signed-rank and Mann-Whitney 464 
test respectively) (B) qPCR confirmation of several TJ proteins significantly downregulated 465 
in severe ACD skin to PPD (severe reactions N=5, mild reactions N=3/4 (data missing from 466 
one vaseline control), NR N=7). mRNA expressions confirmed by PCR were calculated as 467 
arbitrary units (2
(-Ct)
*1000) according to EEF1A expression (C). Heatmap showing the log2 468 
fold change of significantly differentially expressed gap junction, desmosome and keratine 469 
genes in PPD-exposed skin compared to vaseline controls in one or more groups; non-470 
responder (NR), mild ACD reactions (mild) and severe ACD reactions (severe), Significance 471 
in the individual groups are indicated by * (fdr < 0.015) (D). 472 
 473 
Figure 4. Significantly regulated SC proteins in PPD-exposed skin. Heatmap showing 474 
significantly differentially expressed SC proteins in PPD-exposed skin compared to vaseline 475 
controls in one or more groups; non-responder (NR), mild ACD reactions (mild) and severe 476 
ACD reactions (severe), Significance in the individual groups are indicated by * (fdr < 0.015) 477 
(A) significance in the individual groups is indicated by * (fdr < 0.015). (A) Scatter plots for 478 
the 5 significantly differential expressed SC molecules in PPD-exposed severe ACD skin 479 
reactions, Statistical comparisons between groups, were analyzed using paired or non-paired 480 
data (Wilcoxon signed-rank and Mann-Whitney test respectively) (B) qPCR confirmation of 481 
FLG1 and FLG2 in severe ACD reactions to PPD (severe reactions N=5, mild reactions 482 
N=3/4 (data missing from one vaseline control), NR N=7). Gene expression calculated as 483 
arbitrary units (2
(-Ct)
*1000) according to EEF1A expression (C). 484 
 485 
Figure 5. Confocal microscopy images of barrier proteins in human skin biopsies. 486 
Immuno fluorescence imaging of TJ and barrier proteins in non-responder and severe ACD 487 




junction proteins claudin 1(N=4) and CLMP (N=4) (A) and barrier proteins filaggrin 1 (N=1) 489 
and filaggrin 2 (N=3) (. 490 
 491 
Figure 6. Confocal microscopy images of apoptosis and barrier proteins in skin 492 
equivalent cultures, 8 and 24 h after PPD exposure. TUNEL staining showing apoptosis in 493 
skin cultures after 8 and 24 hours after contact with PPD (A). Epidermal barrier proteins 494 
CLDN1 (B), CLMP (C), FLG1 (D) and FLG2 (E) were stained 8 h after PPD exposure. 495 
Vehicle alone (PBS) and 0.5% H2O2 were used as the negative and positive control, 496 
respectively.  497 
 498 
Figure E1. Correlation of TJ and SC gene expression. Heat map showing Pearson 499 
correlation for the differentially expressed TJ and SC genes in PPD-exposed skin, positive 500 
correlations (red) and negative correlations (blue), R adjusted for p= 0.01. (A) All samples 501 
combined and (B) separate heat maps for the 4 groups, severe ACD reactions, mild ACD 502 
reactions, non-responder, and vaseline controls. 503 
Figure E2. Protein expression of claudin 1, CLMP, filaggrin 1 and filaggrin 2 in non-504 
responder skin after PPD exposure. Additional confocal pictures of the remaining non-505 
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Figure 1 – Steengaard Meisser et Al.
Group Pathway N Adjusted 
P-value
NR Serotonin degradation 1 0.005488
NR / Mild: None significant -
Mild: None significant -
Mild / 
Severe




T cell activation 13 0.00000238
4
Apoptosis signaling 11 0.001323
Severe: Apoptosis signaling 39 1.791e-8
CCKR signaling map ST 46 0.00002091
Parkinson disease 28 0.00002171
Interleukin signaling 29 0.00002171
Integrin signaling 39 0.0009766
VEGF signaling pathway 17 0.005042
Inflammation mediated by chemokine 
and cytokine signaling
41 0.006756
Toll receptor signaling 16 0.005042
EGF receptor signaling 27 0.006756
FAS signaling 12 0.005042
B cell activation 17 0.006756
Severe /NR p53 pathway 4 0.002301
All shared T cell activation 8 0.003221






Group Pathway N Adjusted 
P-value
NR None significant -
NR/ Mild: Cholesterol biosynthesis. 3 8.096e-6
Mild: None significant -
Mild / 
Severe
Circadian clock system 3 0.0009422
Severe: Cadherin signaling 70 1.967e-15
Wnt signaling (skin tissue
regeneration)
98 4.009e-12
Severe /NR None significant -
All shared Cholesterol biosynthesis 3 0.0000486
6
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Figure 2– Steengaard Meisser et Al.



























































































































































































































































































































































































































































































































































Figure 5 – Steengaard Meisser et Al.
8
h



















































Figure 6 – Steengaard Meisser et Al.
Figure E1 – Steengaard Meisser et Al.
Figure E2 – Steengaard Meisser et Al.
A Claudin 1
C
VAS PPD
B CLMP
VAS PPD
Filaggrin 2
VAS PPD
